{"transactions":[{"id":4613828,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T22:45:28.000Z","date":"2026-09-05","kind":"exercise","planned":false,"acquired":false,"shares":1712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":5138,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1712},"source":{"system":"sec-edgar","filing":"0001453524-26-000002","document":"wk-form4_1788993926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1453524/000145352426000002/wk-form4_1788993926.xml","form_type":"4"}},{"id":4613827,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T22:45:28.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":6326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter."}],"balance_after":6326,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":6326},"source":{"system":"sec-edgar","filing":"0001453524-26-000002","document":"wk-form4_1788993926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453524/000145352426000002/wk-form4_1788993926.xml","form_type":"4"}},{"id":4613826,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-09T22:45:28.000Z","date":"2026-09-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":668,"price":386.11,"value":257921.48,"ownership":{"direct":true},"balance_after":1963,"source":{"system":"sec-edgar","filing":"0001453524-26-000002","document":"wk-form4_1788993926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453524/000145352426000002/wk-form4_1788993926.xml","form_type":"4"}},{"id":4613825,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Bio-Rad A Common Stock","published_at":"2026-09-09T22:45:28.000Z","date":"2026-09-05","kind":"exercise","planned":false,"acquired":true,"shares":1712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":2631,"source":{"system":"sec-edgar","filing":"0001453524-26-000002","document":"wk-form4_1788993926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453524/000145352426000002/wk-form4_1788993926.xml","form_type":"4"}},{"id":1013051,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Restricted Stock Units","published_at":"2025-10-28T16:29:44.000Z","date":"2025-10-24","kind":"exercise","planned":false,"acquired":false,"shares":1869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":5609,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1869},"source":{"system":"sec-edgar","filing":"0001453524-25-000007","document":"wk-form4_1761668981.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000145352425000007/wk-form4_1761668981.xml","form_type":"4"}},{"id":1013050,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-10-28T16:29:44.000Z","date":"2025-10-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":950,"price":339.75,"value":322762.5,"ownership":{"direct":true},"balance_after":919,"source":{"system":"sec-edgar","filing":"0001453524-25-000007","document":"wk-form4_1761668981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000145352425000007/wk-form4_1761668981.xml","form_type":"4"}},{"id":1013049,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-10-28T16:29:44.000Z","date":"2025-10-24","kind":"exercise","planned":false,"acquired":true,"shares":1869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":1869,"source":{"system":"sec-edgar","filing":"0001453524-25-000007","document":"wk-form4_1761668981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000145352425000007/wk-form4_1761668981.xml","form_type":"4"}},{"id":1045495,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Restricted Stock Units","published_at":"2025-09-09T20:21:33.000Z","date":"2025-09-05","kind":"grant","planned":false,"acquired":true,"shares":6850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":6850,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":6850},"source":{"system":"sec-edgar","filing":"0001453524-25-000004","document":"wk-form4_1757449290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000145352425000004/wk-form4_1757449290.xml","form_type":"4"}},{"id":1225551,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-05T21:48:44.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":4863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":4863,"derivative":{"exercise_price":256.45,"expiration_date":"2035-03-03","underlying":"Bio-Rad A Common Stock","underlying_shares":4863},"source":{"system":"sec-edgar","filing":"0001062993-25-004589","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325004589/form4.xml","form_type":"4"}},{"id":1381723,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Restricted Stock Units","published_at":"2024-10-25T23:33:41.000Z","date":"2024-10-24","kind":"grant","planned":false,"acquired":true,"shares":7478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":7478,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":7478},"source":{"system":"sec-edgar","filing":"0001062993-24-017972","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324017972/form4.xml","form_type":"4"}},{"id":1557816,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2024-03-29T21:15:41.000Z","date":"2024-03-27","kind":"exercise","planned":false,"acquired":false,"shares":3012,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of Laboratory Corporation of America Holdings (\"Labcorp\") Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of Laboratory Corporation of America Holdings (\"Labcorp\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously reported, in connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the \"EMA\") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"As previously reported, in connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the \"EMA\") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of RSUs held by the reporting person."}],"balance_after":1965,"derivative":{"underlying":"Common Stock","underlying_shares":3012},"source":{"system":"sec-edgar","filing":"0000920148-24-000021","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000021/primary_doc.xml","form_type":"4"}},{"id":1557815,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-03-29T21:15:41.000Z","date":"2024-03-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":952,"price":216.57,"value":206174.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":5460.5491,"source":{"system":"sec-edgar","filing":"0000920148-24-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000021/primary_doc.xml","form_type":"4"}},{"id":1557814,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-03-29T21:15:41.000Z","date":"2024-03-27","kind":"exercise","planned":false,"acquired":true,"shares":3012,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of Laboratory Corporation of America Holdings (\"Labcorp\") Common Stock."}],"balance_after":6412.5491,"source":{"system":"sec-edgar","filing":"0000920148-24-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000021/primary_doc.xml","form_type":"4"}},{"id":1626566,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-22T20:04:06.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":500,"price":215.4901,"value":107745.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $215.4901 per share represents a weighted average of sales prices ranging from $215.46 to $215.55 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder\nof the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":3400.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-006252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224006252/form4.xml","form_type":"4"}},{"id":1647310,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T17:15:04.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":false,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 11, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 11, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4977,"derivative":{"underlying":"Common Stock","underlying_shares":201},"source":{"system":"sec-edgar","filing":"0001127602-24-004641","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224004641/form4.xml","form_type":"4"}},{"id":1647309,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-13T17:15:04.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":59,"price":227.45,"value":13419.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":3900.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-004641","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224004641/form4.xml","form_type":"4"}},{"id":1647308,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-13T17:15:04.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":true,"shares":201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":3959.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-004641","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224004641/form4.xml","form_type":"4"}},{"id":1654132,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":false,"shares":138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":5178,"derivative":{"underlying":"Common Stock","underlying_shares":138},"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1654131,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":false,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":5316,"derivative":{"underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1654130,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Non-qualified Stock Options","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":3000,"derivative":{"exercise_price":222.28,"exercise_date":"2025-02-06","expiration_date":"2034-02-05","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1654129,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":5540,"derivative":{"underlying":"Common Stock","underlying_shares":980},"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1654128,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":41,"price":223.71,"value":9172.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":3758.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1654127,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":true,"shares":138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":3799.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1654126,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":78,"price":223.71,"value":17449.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":3661.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1654125,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-08T20:25:25.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":true,"shares":224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":3739.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-003959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003959/form4.xml","form_type":"4"}},{"id":1657340,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2024-02-06T20:56:41.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":false,"shares":246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vested on February 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vested on February 2, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4560,"derivative":{"underlying":"Common Stock","underlying_shares":246},"source":{"system":"sec-edgar","filing":"0001127602-24-003548","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003548/form4.xml","form_type":"4"}},{"id":1657339,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-06T20:56:41.000Z","date":"2024-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":85,"price":221.54,"value":18830.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":3515.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-003548","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003548/form4.xml","form_type":"4"}},{"id":1657338,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2024-02-06T20:56:41.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":true,"shares":246,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":3600.5491,"source":{"system":"sec-edgar","filing":"0001127602-24-003548","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003548/form4.xml","form_type":"4"}},{"id":1705805,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2023-12-19T13:34:24.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":64,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on December 15, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on December 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 170 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of\nthe Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc."}],"balance_after":4806,"derivative":{"underlying":"Common Stock","underlying_shares":64},"source":{"system":"sec-edgar","filing":"0001127602-23-029890","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223029890/form4.xml","form_type":"4"}},{"id":1705804,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2023-12-19T13:34:24.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":19,"price":219.5,"value":4170.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Stock withholding to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 19.4137 shares acquired on May 31, 2023 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan."}],"balance_after":3354.5491,"source":{"system":"sec-edgar","filing":"0001127602-23-029890","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223029890/form4.xml","form_type":"4"}},{"id":1705803,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Common Stock","published_at":"2023-12-19T13:34:24.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 19.4137 shares acquired on May 31, 2023 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan."}],"balance_after":3373.5491,"source":{"system":"sec-edgar","filing":"0001127602-23-029890","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223029890/form4.xml","form_type":"4"}},{"id":1837885,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2023-07-06T00:01:15.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Laboratory Corporation of America Holdings (\"Labcorp\"), performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting restricted stock units (\"RSUs\") of Labcorp pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea (the \"EMA\"). The 2021 PSA was converted into a number of time-vesting Labcorp RSUs based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting on the 30th day following Labcorp's filing of an annual report on Form 10-K that includes audited financial statements with respect to the 3-year period ending December 31, 2023. Amounts are estimates pending finalization of the adjustment ratio pursuant to the EMA."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Laboratory Corporation of America Holdings (\"Labcorp\"), performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting restricted stock units (\"RSUs\") of Labcorp pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea (the \"EMA\"). The 2021 PSA was converted into a number of time-vesting Labcorp RSUs based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting on the 30th day following Labcorp's filing of an annual report on Form 10-K that includes audited financial statements with respect to the 3-year period ending December 31, 2023. Amounts are estimates pending finalization of the adjustment ratio pursuant to the EMA."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4700,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0001127602-23-020293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223020293/form4.xml","form_type":"4"}},{"id":1900036,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Restricted Stock Unit","published_at":"2023-05-09T20:41:50.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":1664,"derivative":{"underlying":"Common Stock","underlying_shares":370},"source":{"system":"sec-edgar","filing":"0001127602-23-015021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223015021/form4.xml","form_type":"4"}},{"id":1900035,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":73910,"kind":"person","name":"DiVincenzo Jonathan P.","position":1,"cik":"0001453524","reported_name":"DiVincenzo Jonathan P.","relationship":{"officer":true,"officer_title":"EVP, Pres, Central Labs & Intl"}}],"security":"Non-qualified Stock Options","published_at":"2023-05-09T20:41:50.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":1200,"derivative":{"exercise_price":223.86,"exercise_date":"2024-02-07","expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001127602-23-015021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223015021/form4.xml","form_type":"4"}}]}